FDA Alerts

The FDA has approved a new spinal cord stimulation system that helps patients manage chronic intractable pain.

The FDA has approved a generic version of Abilify, an injectable drug to reduce chin fat, and recalled hundreds of APIs from the United States.

The FDA has approved new options for the treatment of presbyopia and multiple sclerosis, and issued a recall after an outbreak of listeria.

The US Food and Drug Administration recently approved ivabradine to treat chronic heart failure caused by improper contracting of the left-ventricle and to reduce hospitalization.

The FDA has released its finalized industry guidance for the development of abuse-deterring opioid drugs.

The FDA approved the Impella 2.5 System to help stabilize circulation and heart function during high-risk percutaneous coronary intervention procedures.

I am often surprised that any doctors and medical students miss the mark on what FDA stands for.

...

The FDA has announced the approval of a new antifungal drug to treat adults with invasive aspergillosis and invasive mucormycosis.

The FDA has released its recommendations—based on a report by the WHO—for the vaccine components of next year's trivalent and quadrivalent influenza vaccines.